PLUME: A single-arm phase II trial evaluating the combination of pembrolizumab and lenvatinib in metastatic uveal melanoma (mUM) patients (pts) previously treated or not with tebentafusp.Manuel Rodrigues, Sophie Piperno‐Neumann, Leanne de Koning et al.|Journal of Clinical Oncology|2023Cited by 2
Palliative care outpatient interventions to limit aggressive care at end-of-life for patients with advanced soft tissue sarcomasGrégoire Marret, Thomas Zurecki, Carole Bouleuc et al.|Supportive Care in Cancer|2025Cited by 1